By creating a more true-to-life representation of DNA's environment, researchers have discovered that strand separation may take more mechanical force than the field previously believed.

Ansa is accepting orders for synthetic DNA constructs ranging from 7.5 kb up to 50 kb for various applications.

CRISPR Therapeutics benefits from Casgevy’s approval and a deep pipeline, despite early rollout hurdles and cost challenges.

We recently published an article titled Billionaire Nicholas J. Pritzker’s 8 Stocks with Huge Upside Potential. In this ...

Researchers use generative AI to design synthetic enhancers that can effectively control gene expression in healthy mammalian ...

A study published in the journal Cell marks the first reported instance of generative AI designing synthetic molecules that ...

Ribbon Bio GmbH, the DNA synthesis company, today announced that Jeff Fitzgerald has joined the company as Vice President, Global Head of Sales. With a proven track record in scaling commercial ...

Ansa Biotechnologies, Inc., the trusted partner for DNA synthesis, today announced the launch of its 50 kb DNA synthesis ...

Fraunhofer institutes have launched the BIOSYNTH project, developing a high-throughput microchip platform that uses synthetic DNA to address the ...

A recent study reveals how grapevine cells adapt to sugar starvation by reprogramming their DNA methylation and gene ...

Twist Bioscience's silicon-based DNA writing platform offers competitive advantages in synthetic DNA, NGS consumables, and ...